ORIC Pharmaceuticals Inc.
ORIC | NASDAQ
$13.33
+$0.66 (+5.21%)
Sep 22, 2026, 2:32 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -140.35M | -135.21M | -129.47M | -135.27M | -137.25M | -132.86M | -127.85M | -119.87M | -110.78M | -101.76M | -100.7M | -93.21M | -92.57M | -89.91M | -89.12M | -91.05M | -84.64M | -85.37M | -78.72M | -84.2M | -91.33M | -81.34M |
Depreciation & Amortization | 1.14M | 1.19M | 1.22M | 1.2M | 1.19M | 1.15M | 1.11M | 1.07M | 1.05M | 1.04M | 1.03M | 1.02M | 980K | 968K | 966K | 948K | 944K | 919K | 897K | 902K | 925K | 949K |
Stock-Based Compensation | 25.9M | 25.38M | 18.48M | 17.41M | 16.83M | 15.26M | 20.21M | 18.93M | 17.74M | 16.57M | 15.23M | 14.43M | 13.86M | 14.13M | 14.46M | 14.83M | 14.93M | 10.84M | 9.64M | 7.83M | 6.11M | 7.5M |
Other Working Capital | 275K | -526K | 2.9M | 2.14M | 1.63M | 1.98M | 143K | 773K | -1.14M | -1.73M | 1.78M | 2.52M | 4.66M | 4.11M | 2.47M | -115K | -1.28M | -826K | 1.14M | 351K | -205K | -879K |
Other Non-Cash Items | -374K | -1.26M | 4.01M | 2.62M | 1.26M | -446K | -8.27M | -8.75M | -8.72M | -7.68M | -6.15M | -4.62M | -3.07M | -1.91M | -1M | -274K | 426K | 3.83M | 4.23M | 11.22M | 23.89M | 20.58M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.05M | -974K | -5.46M | -2.74M | -2.5M | 1.65M | 1.97M | -428K | 817K | -3.58M | 4.9M | 5.64M | 4.37M | 3.66M | -445K | -555K | -580K | 2.08M | 4.07M | 2.84M | 1.54M | 423K |
Operating Cash Flow | -111.64M | -110.88M | -111.21M | -116.78M | -120.47M | -115.25M | -112.83M | -109.05M | -99.89M | -95.41M | -85.69M | -76.75M | -76.42M | -73.05M | -75.14M | -76.1M | -68.92M | -67.7M | -59.88M | -61.42M | -58.86M | -51.89M |
Capital Expenditures | -780K | -487K | -872K | -704K | -1.09M | -1.36M | -1.19M | -1.03M | -685K | -757K | -849K | -1.08M | -1.4M | -1.67M | -2.08M | -2.18M | -2.01M | -1.48M | -939K | -961K | -778K | -845K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 310K | 310K | 310K | 310K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -336.54M | -413.13M | -399.82M | -389.16M | -277.67M | -202.19M | -251.92M | -246.26M | -303.24M | -310.25M | -239.24M | -241.91M | -191.94M | -181.57M | -238.12M | -243.25M | -189.93M | -144.39M | -69.63M | -133.71M | -250.66M | -250.66M |
Sales Maturities Of Investments | 237.5M | 225M | 252.5M | 267.5M | 290M | 310M | 275.25M | 247.74M | 223.47M | 192.96M | 196.69M | 206.92M | 214.42M | 177.43M | 130.95M | 108.24M | 90.5M | 173M | 229M | 191.5M | 148.5M | 66M |
Other Investing Acitivies | 223K | 223K | 223K | n/a | -969K | -969K | -969K | -969K | n/a | n/a | -310K | -310K | -310K | -310K | n/a | n/a | n/a | n/a | n/a | 10M | 10M | 10M |
Investing Cash Flow | -99.66M | -188.46M | -148.03M | -122.36M | 11.25M | 106.46M | 22.14M | 445K | -80.46M | -118.05M | -43.4M | -36.07M | 21.08M | -5.81M | -109.25M | -137.2M | -101.44M | 27.13M | 158.44M | 66.83M | -92.93M | -175.5M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -1.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.99M | -1.61M | -616K | -616K | 377K | n/a | 198K | 425K | 425K | 599K | 401K | -33K | -33K | -207K | -207K | n/a | -1.41M | -1.41M | -1.41M | -9.23M | -8.15M | -8.15M |
Financial Cash Flow | 172.92M | 306.39M | 245.51M | 244.58M | 135.26M | 1.77M | 126.72M | 126.59M | 126.5M | 210.86M | 85.66M | 110M | 109.97M | 25.21M | 25.23M | 1.25M | 49.83M | 49.47M | 49.47M | 174.16M | 125.23M | 252.16M |
Net Cash Flow | -38.38M | 7.06M | -13.74M | 5.44M | 26.03M | -7.03M | 36.02M | 17.99M | -53.85M | -2.61M | -43.43M | -2.82M | 54.63M | -53.65M | -159.17M | -212.05M | -120.53M | 8.9M | 148.03M | 179.56M | -26.56M | 24.77M |
Free Cash Flow | -112.42M | -111.36M | -112.08M | -117.49M | -121.56M | -116.61M | -114.02M | -110.07M | -100.58M | -96.17M | -86.54M | -77.83M | -77.83M | -74.72M | -77.22M | -78.28M | -70.93M | -69.18M | -60.82M | -62.38M | -59.64M | -52.74M |
Adj. Free Cash Flow | -138.32M | -136.74M | -130.57M | -134.9M | -138.39M | -131.86M | -134.23M | -129.01M | -118.32M | -112.74M | -101.76M | -92.26M | -91.69M | -88.85M | -91.68M | -93.11M | -85.87M | -80.02M | -70.46M | -70.21M | -65.75M | -60.23M |
Maintenance CapEx | -621K | -420K | -720K | -619K | -854K | -1.06M | -979K | -817K | -624K | -611K | -646K | -836K | -980K | -968K | -966K | -948K | -944K | -832K | -763K | -768K | -601K | -668K |
Growth CapEx | -159K | -67K | -152K | -85K | -233K | -294K | -209K | -209K | -61K | -146K | -203K | -243K | -423K | -697K | -1.11M | -1.23M | -1.07M | -648K | -176K | -193K | -177K | -177K |
Owner Earnings | -112.26M | -111.3M | -111.93M | -117.4M | -121.32M | -116.31M | -113.81M | -109.86M | -100.52M | -96.03M | -86.33M | -77.58M | -77.4M | -74.02M | -76.11M | -77.05M | -69.86M | -68.53M | -60.64M | -62.19M | -59.46M | -52.56M |
Add to Watchlist
Select watchlists to add or remove ORIC